Fever of Unknown Orgin Registry in Internal Medicine Unit and Infectious Disease Units

Fever of Unknown Origin Clinical Trial

— FUO  

Official title:

Fever of Unknown Orgin Registry in Internal Medicine Unit and Infectious Disease Units

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05254522
• Other study ID #: FADOI.07.2018
• Status: Recruiting
• Start date: September 19, 2019
• Est. completion date: December 2022

Study information

• Verified date: February 2022
• Source: Fadoi Foundation, Italy
• Contact: ELISA ZAGARRI'
• Phone: +39 0248005140
• Email: elisa.zagarri[@]fadoi.org
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This registry has the aim to collect epidemiological and clinical data of classical FUO cases in Italian Internal medicine Dept. and in Italian Infection diseases Dept.

Description:

In particular this registry intends to record clinical data observed, diagnostic methods used and the clinical evolution of classical FUO cases

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: December 2022
• Est. primary completion date: December 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• • fever (temperature > 38.3° C) found in several occasions of a duration exceeding 3, unable to make a diagnosis after a period of 3 days of hospitalization or after 3 out-patients visits in Internal Medicine Dept. or Infection Diseases Dept.
• signed informed consent

Exclusion Criteria:

• • immunocompromised patients
• patients in treatment with steroidi (prednisone > 0,5 mg/Kg/die per > 4 weeks), anti-TNF, ciclofosfamide, tacrolimus, everolimus, sirolimus, azatioprina, ciclosporina, micofenolato, metotrexate
• neutropenic patients with less than 500 neutrofili/µL
• HIV positive patients
• nocosomial fever.

Related Conditions & MeSH terms

• Communicable Diseases
• Fever
• Fever of Unknown Origin
• Infections

Intervention

Other:
• not aplicable since it is a Registry
not aplicable since it is a registry

Locations

Country	Name	City	State
Italy	ASUI di Trieste	Trieste

Sponsors (1)

Lead Sponsor	Collaborator
Fadoi Foundation, Italy

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To describe FUO cases collected	To describe clinical evolution of classical FUO cases recording clinical data observed, diagnostic methods used.	6 moths